MDxHealth SA (MDXH) Tops Q4 EPS by 5c, Beats on Revenue

MDxHealth SA (NASDAQ: MDXH) reported Q4 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $24.74 million versus the consensus estimate of $22.9 million.

GUIDANCE:

MDxHealth SA sees FY2025 revenue of $108-110 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Boeing wins $121 million Navy contract for P-8A upgrades
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval